PERRIGO CO PLC (PRGO)
IE00BGH1M568 - Common Stock
PERRIGO CO PLC
NYSE:PRGO (4/25/2024, 7:12:20 PM)
After market: 31.27 0 (0%)31.27
+0.04 (+0.13%)
Company Profile
Perrigo Co. Plc engages in the provision of self-care products and over-the-counter (OTC) health and wellness solutions. The company is headquartered in Dublin, Dublin and currently employs 8,900 full-time employees. The firm's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
Company Info
PERRIGO CO PLC
The Sharp Building, Hogan Place, Dublin 2
DUBLIN DUBLIN 49010
P: 35317094000
CEO: Murray S. Kessler
Employees: 8900
Website: https://www.perrigo.com/
PRGO News
a day ago - Perrigo Company plcPerrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 MillionProposed Divestment of Branded Prescription Pharma Business Further Supports Perrigo's Strategic Focus on Consumer Self-Care Total Purchase Consideration of up...
3 days ago - Perrigo Company plcPerrigo to Release First Quarter 2024 Financial Results on May 7, 2024/PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its first quarter...
22 days ago - BloombergCVS to Cover Opill Over-the-Counter Birth Control Drug in USCVS Health Corp. drug plans will cover over-the-counter oral birth control in the US, a step that further removes barriers to obtaining oral contraception as reproductive rights increasingly come under fire.
a month ago - Market News VideoInteresting PRGO Put And Call Options For November 15th2 months ago - Market News VideoNoteworthy Wednesday Option Activity: XPO, PRGO, HZO
2 months ago - Perrigo Company plcPerrigo Commences Shipments of Opill® to Retailers Nationwide, Empowering Millions to Enter a New Era of Reproductive Health Access in the United States/PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that Opill® has shipped to major retailers...
PRGO Twits
Here you can normally see the latest stock twits on PRGO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
